These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2801951)

  • 1. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor.
    Chang SW; Ohara N; Kuo G; Voelkel NF
    Am J Physiol; 1989 Oct; 257(4 Pt 1):L232-9. PubMed ID: 2801951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury.
    Chang SW; Fernyak S; Voelkel NF
    Am J Physiol; 1990 Jan; 258(1 Pt 2):H153-8. PubMed ID: 2301603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1990 Mar; 68(3):1059-68. PubMed ID: 2341334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
    J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary tumor necrosis factor triggers local platelet-activating factor production in rat immune complex alveolitis.
    Warren JS; Barton PA; Mandel DM; Matrosic K
    Lab Invest; 1990 Dec; 63(6):746-54. PubMed ID: 2255183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of WEB 2086 and SRI 63-441 on TNF-alpha-induced alterations in cardiopulmonary function.
    Kruse-Elliott KT; Dodam JR; Johnson LW; Olson NC
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H761-70. PubMed ID: 1415600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV; Slotman GJ
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
    Pedersen KE; Rigby PJ; Goldie RG
    Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat.
    McCormack DG; Barnes PJ; Evans TW
    Clin Sci (Lond); 1989 Oct; 77(4):439-43. PubMed ID: 2805602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
    Pritze S; Simmet T; Peskar BA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activating factor mediates interleukin-2-induced lung injury in the rat.
    Rabinovici R; Sofronski MD; Renz JF; Hillegas LM; Esser KM; Vernick J; Feuerstein G
    J Clin Invest; 1992 May; 89(5):1669-73. PubMed ID: 1314853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.
    Rabinovici R; Esser KM; Lysko PG; Yue TL; Griswold DE; Hillegass LM; Bugelski PJ; Hallenbeck JM; Feuerstein G
    Circ Res; 1991 Jul; 69(1):12-25. PubMed ID: 1647275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist.
    Casals-Stenzel J; Franke J; Friedrich T; Lichey J
    Br J Pharmacol; 1987 Aug; 91(4):799-802. PubMed ID: 3664079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids.
    Chen CR; Voelkel NF; Chang SW
    Am J Respir Crit Care Med; 1994 Jan; 149(1):34-40. PubMed ID: 8111595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of PAF receptor antagonism on cardiopulmonary alterations during coinfusion of TNF-alpha and IL-1 alpha in pigs.
    Kruse-Elliott KT; Pino MV; Olson NC
    Am J Physiol; 1993 Feb; 264(2 Pt 1):L175-82. PubMed ID: 8383447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity.
    Heuer H
    Prog Clin Biol Res; 1989; 308():919-24. PubMed ID: 2780739
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport.
    Horvath CJ; Kaplan JE; Malik AB
    Am Rev Respir Dis; 1991 Dec; 144(6):1337-41. PubMed ID: 1741548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.